Severe hypofibrinogenemia in patients bitten by Gloydius tsushimaensis in Tsushima Island, Nagasaki, Japan, and treatment strategy.


Journal

Toxicon : official journal of the International Society on Toxinology
ISSN: 1879-3150
Titre abrégé: Toxicon
Pays: England
ID NLM: 1307333

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 25 06 2020
revised: 09 10 2020
accepted: 29 10 2020
pubmed: 2 11 2020
medline: 20 11 2020
entrez: 1 11 2020
Statut: ppublish

Résumé

Gloydius tsushimaensis is an endemic species inhabiting only Tsushima, a remote Japanese island, and is a distinct species from Gloydius blomhoffii widely distributed throughout mainland Japan and Gloydius brevicaudus and Gloydius ussuriensis which are geographically distributed in South Korea. This is the first multicenter retrospective study of G. tsushimaensis bites in Japan. A study of seventy-two patients who visited the former Izuhara Hospital, the former Naka Tsushima Hospital, Tsushima Hospital, and Kamitsushima Hospital during the fourteen years from January 1, 2005, to December 31, 2018, revealed the typical clinical characteristics of G. tsushimaensis bites. Five out of seventy-two cases (6.9%) showed severe hypofibrinogenemia, in which fibrinogen levels were below 100 mg/dl, which is an unreported clinical finding for G. blomhoffii bites. Generally, when fibrinogen levels are lower than 100 mg/dl, the bleeding risk increases, and it is perilous. Severe hypofibrinogenemia cases did not improve after G. blomhoffii antivenom administration. Additionally, all five cases had disseminated intravascular coagulation, and there were two cases of acute kidney injury and one death. five cases had a median maximum creatine kinase level of 5171 IU/l (Interquartile range: 4992-41,310). Although the mechanism is not precise, coagulation tests showed that the G. tsushimaensis venom contains a thrombin-like enzyme. Based on this research, we created an algorithm for the treatment of G. tsushimaensis bites and unified the treatment methods used on the island.

Identifiants

pubmed: 33130186
pii: S0041-0101(20)30437-2
doi: 10.1016/j.toxicon.2020.10.027
pii:
doi:

Substances chimiques

Antivenins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

142-149

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Auteurs

Hideto Yokoi (H)

Department of Emergency Medicine, Yokohama City University, 4-57 Urafunecho Minami-ku Yokohama, Kanagawa, 232-0024, Japan; Nagasaki Prefecture Tsushima Hospital, 1168-7 Mitsushima-cho Kechi, Tsushima, Nagasaki, 817-0322, Japan. Electronic address: hideto451@gmail.com.

Atsushi Sakai (A)

The Japan Snake Institute, 3318 Yabuzuka-cho, Ohata, Gunma, 379-2301, Japan.

Tomonori Kodama (T)

Department of Zoology, Graduate School of Science, Kyoto University, Kirashirakawa-oiwake-cho, Sakyo, Kyoto, 606-8502, Japan.

Shogo Magome (S)

Nagasaki Prefecture Tsushima Hospital, 1168-7 Mitsushima-cho Kechi, Tsushima, Nagasaki, 817-0322, Japan.

Tadanori Nagayasu (T)

Nagasaki Prefecture Tsushima Hospital, 1168-7 Mitsushima-cho Kechi, Tsushima, Nagasaki, 817-0322, Japan.

Masayuki Tawara (M)

Nagasaki Prefecture Tsushima Hospital, 1168-7 Mitsushima-cho Kechi, Tsushima, Nagasaki, 817-0322, Japan.

Taizo Hasegawa (T)

Nagasaki Prefecture Kami Tsushima Hospital, 630 Kamitsushima-cho Hitakatsu, Tsushima, Nagasaki, 817-1701, Japan.

Takahiro Yasaka (T)

Nagasaki Prefecture Tsushima Hospital, 1168-7 Mitsushima-cho Kechi, Tsushima, Nagasaki, 817-0322, Japan.

Takeru Abe (T)

Department of Emergency Medicine, Yokohama City University, 4-57 Urafunecho Minami-ku Yokohama, Kanagawa, 232-0024, Japan.

Ichiro Takeuchi (I)

Department of Emergency Medicine, Yokohama City University, 4-57 Urafunecho Minami-ku Yokohama, Kanagawa, 232-0024, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH